The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to procure a NextSeq 2000 Silver Support Plan from Illumina, Inc. This procurement is essential for maintaining high throughput sequencing capabilities that are critical for research into immune responses against infectious diseases, particularly through RNA sequencing methods. The support plan includes comprehensive service coverage, preventive maintenance, remote technical support, and timely on-site response during the performance period from November 1, 2024, to July 4, 2025. Interested parties must submit capability statements by October 28, 2024, to Angela Puddy at angela.puddy@nih.gov, as this is not a request for proposals and the Government retains discretion regarding competition for this requirement.